Skip to main navigation Skip to search Skip to main content

A Potential Next Generation Sclerostin Inhibitor Specifically Targets Sclerostin Monomer for Bone Anabolic Therapy with Low Cardiovascular Risk to Reverse Established Osteoporosis in Ovariectomized Rats (Abstract)

  • Yuanyuan Yu
  • , Qing Ren
  • , Shuaijian Ni
  • , Jin Liu
  • , Chuanxin Zhong
  • , Jun Lu
  • , Yuan Tang
  • , Dijie Li
  • , Duoli Xie
  • , Rongchen Dai
  • , Huarui Zhang
  • , Lei Dang
  • , Aiping Lyu
  • , Ge Zhang
  • , Zhenjian Zhuo
  • , Zong-Kang Zhang
  • , Bao Ting Zhang
  • , Luyao Wang
  • , Yongshu Li
  • , Kui Kwan Wong
  • Joseph Zhai

Research output: Contribution to journalConference articlepeer-review

Original languageEnglish
Pages (from-to)264
Number of pages1
JournalJournal of Bone and Mineral Research
Volume34
Issue numberS1
DOIs
Publication statusPublished - Dec 2019
Event2019 Annual Meeting of the American Society for Bone and Mineral Research, ASBMR 2019 - Orange County Convention Center, Orlando, United States
Duration: 20 Sept 201923 Sept 2019
https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.3936 (Conference abstract (Wiley))
https://academic.oup.com/jbmr/issue/34/S1 (Conference abstract (OUP))

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this